Clinical Trial: An Open-label Study That Will Test a Second Treatment Session of RZL-012.
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Submental Fat
Study Type: INTERVENTIONAL
Official Title: An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of a Second Treatment Session of RZL-012 Into Submental Fat in Subjects Seeking Further Improvement
Brief Summary:
This is a Phase 2, open-label study in which subjects seeking further improvement of their SMF will be treated with a second treatment session of RZL-012.The second treatment session will be offered to subjects previously treated with RZL-012 under protocols RZL-012-SMF-SWMTG-P2US-001 or RZL-012-SMFC-P2US-001.Subjects who fully completed either of the trials and whose C-CAT score is 2, 3 or 4 will be eligible to participate in the new trial.For each subject, the study will consist of a screening period, baseline…
Read more